OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease
Linda Anna Michelle Kulka, Pia-Victoria Fangmann, Diana Panfilova, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
Md Abdus Subhan, Farzana Parveen, Hassan Shah, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2204-2204
Open Access | Times Cited: 50

HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
Valentina Condelli, Fabiana Crispo, Michele Pietrafesa, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 532-532
Open Access | Times Cited: 83

The emerging roles of HDACs and their therapeutic implications in cancer
Rihan Hai, Deyi Yang, Feifei Zheng, et al.
European Journal of Pharmacology (2022) Vol. 931, pp. 175216-175216
Closed Access | Times Cited: 48

Autophagy and Exosomes Relationship in Cancer: Friends or Foes?
Marta Colletti, Donatella Ceglie, Angela Di Giannatale, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 42

The pharmacoepigenetic paradigm in cancer treatment
Belén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6

Role of autophagy in drug resistance and regulation of osteosarcoma (Review)
Yanchuan Pu, Jin Wang, Shizhong Wang
Molecular and Clinical Oncology (2022) Vol. 16, Iss. 3
Open Access | Times Cited: 23

Histone deacetylase (HDACs) inhibitors: Clinical applications
Kumar D. Shanmukha, Harikrishnareddy Paluvai, Santosh K. Lomada, et al.
Progress in molecular biology and translational science (2023), pp. 119-152
Closed Access | Times Cited: 14

A Perspective of Epigenetic Regulation in Radiotherapy
Peng Qin, Kegui Weng, Shitian Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27

Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies
Yi Wang, Qiang Xie, Huidan Tan, et al.
Pharmacological Research (2021) Vol. 173, pp. 105702-105702
Closed Access | Times Cited: 26

Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment
Tung-Yun Wu, Michael Chen, I‐Chung Chen, et al.
Journal of Advanced Research (2022) Vol. 46, pp. 159-171
Open Access | Times Cited: 17

Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells
Hae-Ryung Cho, Woo-Chang Son, Young-Shin Lee, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3952-3952
Open Access | Times Cited: 19

Epigenetic therapeutic strategies in pancreatic cancer
Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda
International review of cell and molecular biology (2024), pp. 1-40
Closed Access | Times Cited: 2

Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 752-752
Open Access | Times Cited: 2

Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer
Lennart Versemann, Elisabeth Heßmann, Maria Ulisse
Visceral Medicine (2021) Vol. 38, Iss. 1, pp. 11-19
Open Access | Times Cited: 16

Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials
Plinio A. Trinidad-Calderón, Carlos Daniel Varela-Chinchilla, Silverio García‐Lara
Molecules (2023) Vol. 28, Iss. 2, pp. 670-670
Open Access | Times Cited: 6

Therapeutic Targeting of Cancer: Epigenetic Homeostasis
Xiaoyuan Yu, Menglu Li, Chunyan Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13

Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats
Mahshid Badrikoohi, Aghil Esmaeili-Bandboni, Parvin Babaei
Brain Research Bulletin (2021) Vol. 179, pp. 49-56
Closed Access | Times Cited: 13

A Comprehensive Analysis of the Effects of Key Mitophagy Genes on the Progression and Prognosis of Lung Adenocarcinoma
Dongjun Dai, Lihong Liu, Yinglu Guo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 57-57
Open Access | Times Cited: 8

Identification of Tumor Microenvironment-Related Prognostic Genes in Sarcoma
Dongjun Dai, Lanyu Xie, Yongjie Shui, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 11

Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion
Alexandra L. Nguyen, Melanie Dzulko, Janine Murr, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2520-2520
Open Access | Times Cited: 8

Discovery of Potent and Isoform‐selective Histone Deacetylase Inhibitors Using Structure‐based Virtual Screening and Biological Evaluation
Zhe Peng, Quanfeng Zhao, Xiaoyan Tian, et al.
Molecular Informatics (2022) Vol. 41, Iss. 9
Closed Access | Times Cited: 5

Novel insights into the progression and prognosis of the calpain family members in hepatocellular carcinoma: a comprehensive integrated analysis
Dongjun Dai, Dehao Wu, Runliang Ni, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top